Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlos A Alvarez

Showing results (11-20 of 117) with videos related to

Pageof 12
Sort By:
Elife|February 22, 2021
Integration of IL-2 and IL-4 signals coordinates divergent regulatory T cell responses and drives therapeutic efficacyJulie Y Zhou, Carlos A Alvarez, Brian A Cobb
Diabetes & Vascular Disease Research|February 19, 2015
Sodium-glucose co-transporter inhibition in the treatment of diabetes: sweetening the potCarlos A Alvarez, Ian J Neeland, Darren K McGuire
The American Journal of Geriatric Pharmacotherapy|May 1, 2012
Effects of oral bisphosphonate therapy on serum calcium in elderly veterans with poor kidney functionScott Martin Vouri, Carlos A Alvarez, Amie Taggart Blaszczyk
JAMA|October 1, 2014
Azithromycin for elderly patients with pneumonia--replyEric M Mortensen, Carlos A Alvarez, Ethan A Halm
The Annals of Pharmacotherapy|February 6, 2018
Association of Statin Therapy With Risk of Epilepsy in 2 Propensity Score-Matched CohortsLakshya U Trivedi, Carlos A Alvarez, Ishak A Mansi
International Braz J Urol : Official Journal of the Brazilian Society of Urology|March 8, 2006
Primary diffuse large B-cell lymphoma of the prostate in a young patientCarlos A Alvarez, Begona I Rodriguez, Luis A Perez
Biomedica : Revista Del Instituto Nacional De Salud|August 24, 2007
[Make your own diagnosis: part one]Carlos A Alvarez, Angel Sánchez, Alexander Morales, et al.
Biomedica : Revista Del Instituto Nacional De Salud|August 24, 2007
[Make your own diagnosis: part two]Carlos A Alvarez, Angel Sánchez, Alexander Morales, et al.
Antibiotics (Basel, Switzerland)|March 25, 2022
The Risk of <i>Clostridioides difficile</i> Recurrence after Initial Treatment with Vancomycin or Fidaxomicin Utilizing Cerner Health FactsRonald G Hall, Travis J Cole, Chip Shaw, et al.
Frontiers in Immunology|November 16, 2020
Characterization of Polysaccharide A Response Reveals Interferon Responsive Gene Signature and Immunomodulatory Marker ExpressionCarlos A Alvarez, Mark B Jones, John Hambor, et al.
Pageof 12

Showing results (11-20 of 117) with videos related to

Sort By:
Pageof 12
Elife|February 22, 2021
Integration of IL-2 and IL-4 signals coordinates divergent regulatory T cell responses and drives therapeutic efficacyJulie Y Zhou, Carlos A Alvarez, Brian A Cobb
Diabetes & Vascular Disease Research|February 19, 2015
Sodium-glucose co-transporter inhibition in the treatment of diabetes: sweetening the potCarlos A Alvarez, Ian J Neeland, Darren K McGuire
The American Journal of Geriatric Pharmacotherapy|May 1, 2012
Effects of oral bisphosphonate therapy on serum calcium in elderly veterans with poor kidney functionScott Martin Vouri, Carlos A Alvarez, Amie Taggart Blaszczyk
JAMA|October 1, 2014
Azithromycin for elderly patients with pneumonia--replyEric M Mortensen, Carlos A Alvarez, Ethan A Halm
The Annals of Pharmacotherapy|February 6, 2018
Association of Statin Therapy With Risk of Epilepsy in 2 Propensity Score-Matched CohortsLakshya U Trivedi, Carlos A Alvarez, Ishak A Mansi
International Braz J Urol : Official Journal of the Brazilian Society of Urology|March 8, 2006
Primary diffuse large B-cell lymphoma of the prostate in a young patientCarlos A Alvarez, Begona I Rodriguez, Luis A Perez
Biomedica : Revista Del Instituto Nacional De Salud|August 24, 2007
[Make your own diagnosis: part one]Carlos A Alvarez, Angel Sánchez, Alexander Morales, et al.
Biomedica : Revista Del Instituto Nacional De Salud|August 24, 2007
[Make your own diagnosis: part two]Carlos A Alvarez, Angel Sánchez, Alexander Morales, et al.
Antibiotics (Basel, Switzerland)|March 25, 2022
The Risk of <i>Clostridioides difficile</i> Recurrence after Initial Treatment with Vancomycin or Fidaxomicin Utilizing Cerner Health FactsRonald G Hall, Travis J Cole, Chip Shaw, et al.
Frontiers in Immunology|November 16, 2020
Characterization of Polysaccharide A Response Reveals Interferon Responsive Gene Signature and Immunomodulatory Marker ExpressionCarlos A Alvarez, Mark B Jones, John Hambor, et al.
Pageof 12